PEP-Therapy
Angelita Rebollo is the Co-founder & Scientific Advisor at PEP-Therapy. Angelita is also a Research Director at the Center for Immunology and Infectious Diseases (CIMI, Inserm / UPMC / CNRS). Expertise in apoptosis and in the design of Cell-Penetrating & Interfering Peptides.
This person is not in the org chart
This person is not in any offices
PEP-Therapy
PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology based on the Company’s innovative Cell-Penetrating and Interfering Peptides (CP&IP) technology.